• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与免疫治疗反应相关的阿克曼氏菌:煤矿里的金丝雀?

Immunotherapy response-associated Akkermansia: canary in a coal mine?

作者信息

Cascone Tina, Chelvanambi Manoj, Wargo Jennifer A

机构信息

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Trends Immunol. 2022 May;43(5):337-339. doi: 10.1016/j.it.2022.03.007. Epub 2022 Apr 6.

DOI:10.1016/j.it.2022.03.007
PMID:35397955
Abstract

Gut microbes can shape cancer immunotherapy responses; however, specific taxa have not been tested prospectively as biomarkers. Derosa and colleagues now demonstrate that the presence of Akkermansia muciniphila in baseline stool samples can be associated with improved outcomes and enhanced antitumor immune cell infiltrates in patients with lung cancer treated with immune checkpoint blockade (ICB).

摘要

肠道微生物可影响癌症免疫治疗反应;然而,尚未对特定的微生物分类群作为生物标志物进行前瞻性测试。德罗萨及其同事现在证明,在接受免疫检查点阻断(ICB)治疗的肺癌患者中,基线粪便样本中存在嗜黏蛋白阿克曼氏菌可能与更好的治疗结果及增强的抗肿瘤免疫细胞浸润有关。

相似文献

1
Immunotherapy response-associated Akkermansia: canary in a coal mine?与免疫治疗反应相关的阿克曼氏菌:煤矿里的金丝雀?
Trends Immunol. 2022 May;43(5):337-339. doi: 10.1016/j.it.2022.03.007. Epub 2022 Apr 6.
2
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.肠道细菌组成驱动肾细胞癌患者对癌症免疫疗法的原发性耐药性。
Eur Urol. 2020 Aug;78(2):195-206. doi: 10.1016/j.eururo.2020.04.044. Epub 2020 May 4.
3
Too much water drowned the miller: Akkermansia determines immunotherapy responses.水多了反而把磨坊给淹了:阿克曼氏菌决定免疫治疗反应。
Cell Rep Med. 2022 May 17;3(5):100642. doi: 10.1016/j.xcrm.2022.100642.
4
[Association between Immunotherapy with Immune Checkpoint Inhibitors(Anti-PD-1 Antibodies)and Intestinal Microbiota].免疫检查点抑制剂(抗PD-1抗体)免疫治疗与肠道微生物群之间的关联
Gan To Kagaku Ryoho. 2021 Sep;48(9):1096-1099.
5
Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy.嗜黏蛋白阿克曼氏菌:提高癌症免疫治疗效果的潜在助力因素。
J Cancer Res Clin Oncol. 2023 Nov;149(14):13477-13494. doi: 10.1007/s00432-023-05199-8. Epub 2023 Jul 25.
6
Predictive power of different Akkermansia phylogroups in clinical response to PD-1 blockade against non-small cell lung cancer.不同阿克曼氏菌系统发育群对非小细胞肺癌患者PD-1阻断治疗临床反应的预测能力
bioRxiv. 2024 Aug 22:2024.08.21.608814. doi: 10.1101/2024.08.21.608814.
7
Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.共生微生物群有助于预测非小细胞肺癌患者对免疫检查点抑制剂的反应。
Cancer Sci. 2021 Aug;112(8):3005-3017. doi: 10.1111/cas.14979. Epub 2021 Jun 23.
8
therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.质子泵抑制剂会降低肺癌患者免疫检查点抑制剂的疗效,而治疗则可恢复这种疗效。
Oncoimmunology. 2022 May 27;11(1):2081010. doi: 10.1080/2162402X.2022.2081010. eCollection 2022.
9
HYR-2 plays an anti-lung cancer role by regulating PD-L1 and Akkermansia muciniphila.HYR-2 通过调节 PD-L1 和阿克曼氏菌发挥抑癌作用。
Pharmacol Res. 2020 Oct;160:105086. doi: 10.1016/j.phrs.2020.105086. Epub 2020 Jul 17.
10
Immunotherapy for ovarian cancer.卵巢癌的免疫治疗。
Clin Adv Hematol Oncol. 2022 Apr;20(4):240-253.

引用本文的文献

1
The Impact of Uranium-Induced Pulmonary Fibrosis on Gut Microbiota and Related Metabolites in Rats.铀诱导的肺纤维化对大鼠肠道微生物群及相关代谢产物的影响
Metabolites. 2025 Jul 22;15(8):492. doi: 10.3390/metabo15080492.
2
Multi-Omics Analysis Reveals Intratumor Microbes as Immunomodulators in Colorectal Cancer.多组学分析揭示肿瘤内微生物是结直肠癌中的免疫调节因子。
Microbiol Spectr. 2023 Feb 14;11(2):e0503822. doi: 10.1128/spectrum.05038-22.